USPTO serial 78219716
LIQDOSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CLARK, GLENN
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with LIQDOSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrea A. Jacobs
PETER F CORLESS EDWARDS & ANGELL LLPPO BOX 55874BOSTON, MA 02205UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical and medical preparations for physical and mental disorders, pharmaceutical and medical preparations for the use of veterinarians, pharmaceutical controlled release systems, pharmaceutical modified release systems, drug delivery systems, drug design, drug formulation | ACTIVE | — |
| 040 | Testing of medical substances, testing of medical applications, development of drug design, development of pharmaceutical formulation, development of drug delivery systems, development of mixing technology, development of particulate material, development of particulate material mixing technology, development of granulation technology, development of tabletting technology, development of solid dosage forms, development of pharmaceutical controlled release systems, development of pharmaceutical modified release systems | ACTIVE | — |
| 041 | Education, namely, providing of training, arranging and conducting of seminars, arranging and conducting of workshops, arranging and conducting of conferences, arranging and conducting of lectures, arranging and conducting of congresses, all in the medical, chemical and pharmaceutical fields; and education and training services; all in the medical, chemical and pharmaceutical fields | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto; industrial analysis and research services; bacteriological research, biological research, scientific research services for medical purposes, research consultation, scientific consultation, pharmaceutical and medical consultation (other than doctor/patient), cosmetic research, design services (medical packaging and equipment), pharmaceutical and medical research, testing of medical substances, development of medical substances, testing of medical applications, development of medical applications, drug design, drug formulation, pharmaceutical formulation, development of pharmaceutical formulation, consultancy regarding pharmaceutical formulation, development of drug delivery systems, consultancy regarding drug delivery systems, development of mixing technology, consultancy regarding mixing technology, development of particulate material, consultancy regarding particulate material, development of particulate material mixing technology, consultancy regarding particulate mixing technology, development of granulate technology, consultancy regarding granulation technology, development of tableting technology, consultancy regarding tableting technology, development of solid dosage forms, consultancy regarding solid dosage forms, development of pharmaceutical controlled release systems, consultancy regarding pharmaceutical controlled release systems, pharmaceutical controlled release systems, development of pharmaceutical modified release systems, consultancy regarding pharmaceutical modified release systems, pharmaceutical modified release systems, drug delivery systems | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Pharotech A/S
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Similar marks named LIQDOSE
- Prosecution event ABN2 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 6, 2004 | ABN2 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time. |
| Feb 17, 2004 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 25, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 20, 2003 | DOCK | ASSIGNED TO EXAMINER | — |